Compare DNLI & PARR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DNLI | PARR |
|---|---|---|
| Founded | 2013 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Integrated oil Companies |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.4B |
| IPO Year | 2017 | 2000 |
| Metric | DNLI | PARR |
|---|---|---|
| Price | $18.42 | $63.51 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 21 | 8 |
| Target Price | $35.82 | ★ $94.38 |
| AVG Volume (30 Days) | ★ 1.3M | 765.8K |
| Earning Date | 11-03-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1313.56 |
| EPS | N/A | ★ 17.54 |
| Revenue | N/A | ★ $2,443,066,000.00 |
| Revenue This Year | N/A | $42.03 |
| Revenue Next Year | $204.90 | N/A |
| P/E Ratio | ★ N/A | $3.67 |
| Revenue Growth | N/A | ★ 30.99 |
| 52 Week Low | $15.34 | $34.37 |
| 52 Week High | $27.30 | $90.74 |
| Indicator | DNLI | PARR |
|---|---|---|
| Relative Strength Index (RSI) | 43.32 | 33.13 |
| Support Level | $18.24 | $55.45 |
| Resistance Level | $21.45 | $68.89 |
| Average True Range (ATR) | 0.94 | 3.52 |
| MACD | -0.10 | -0.43 |
| Stochastic Oscillator | 24.50 | 2.75 |
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.
Par Pacific Holdings Inc is an oil and gas company that manages and maintains interests in energy and infrastructure businesses. The company has three reportable segments: Refining. Under its refining business, the company produces ultra-low-sulfur diesel, gasoline, jet fuel, marine fuel, LSFO, and other associated refined products. Its Retail includes operating licenses out brands to serve the retail consumer. Through the Logistics segment, crude shipments are delivered to the refineries, in addition to finished products that are exported. It generates maximum revenue from the Refining segment.